Dual- Isolation and Profiling of Circulating Tumor Cells and Cancer Exosomes from Blood Samples with Melanoma Using Immunoaffinity- Based Microfluidic Interfaces
dc.contributor.author | Kang, Yoon‐tae | |
dc.contributor.author | Hadlock, Thomas | |
dc.contributor.author | Lo, Ting‐wen | |
dc.contributor.author | Purcell, Emma | |
dc.contributor.author | Mutukuri, Anusha | |
dc.contributor.author | Fouladdel, Shamileh | |
dc.contributor.author | Raguera, Monica De Silva | |
dc.contributor.author | Fairbairn, Heather | |
dc.contributor.author | Murlidhar, Vasudha | |
dc.contributor.author | Durham, Alison | |
dc.contributor.author | McLean, Scott A. | |
dc.contributor.author | Nagrath, Sunitha | |
dc.date.accessioned | 2020-11-04T16:01:10Z | |
dc.date.available | WITHHELD_12_MONTHS | |
dc.date.available | 2020-11-04T16:01:10Z | |
dc.date.issued | 2020-10 | |
dc.identifier.citation | Kang, Yoon‐tae ; Hadlock, Thomas; Lo, Ting‐wen ; Purcell, Emma; Mutukuri, Anusha; Fouladdel, Shamileh; Raguera, Monica De Silva; Fairbairn, Heather; Murlidhar, Vasudha; Durham, Alison; McLean, Scott A.; Nagrath, Sunitha (2020). "Dual- Isolation and Profiling of Circulating Tumor Cells and Cancer Exosomes from Blood Samples with Melanoma Using Immunoaffinity- Based Microfluidic Interfaces." Advanced Science 7(19): n/a-n/a. | |
dc.identifier.issn | 2198-3844 | |
dc.identifier.issn | 2198-3844 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/163448 | |
dc.description.abstract | Melanoma is among the most aggressive cancers, and its rate of incidence continues to grow. Early detection of melanoma has been hampered due to the lack of promising markers for testing. Recent advances in liquid biopsy have proposed noninvasive alternatives for cancer diagnosis and monitoring. Circulating tumor cells (CTCs) and cancer- exosomes are gaining influence as promising biomarkers because of their cancer- associated molecular markers and signatures. However, technologies that offer the dual- isolation of CTCs and exosomes using a single sample have not been thoroughly developed. The dual- utilization OncoBean (DUO) device is conjugated with melanoma specific antibodies, MCAM and MCSP, enabling simultaneous CTC and exosome isolations. Using blood samples from patients, CTCs and exosomes are specifically isolated from a single sample and then undergo molecular profiling for comprehensive study. Melanoma patients have 0- 17CTCs mL- 1 and 299 µg exosomal protein mL- 1 while healthy donors display fewer than 2CTCs and 75.6 µg of exosomes mL- 1, respectively. It is also demonstrated that both markers express melanoma- associated genes using multiplex qRT- PCR to test for expression pattern of a 96 gene panel. The dual isolation and molecular characterization will allow for further research into melanoma to identify viable markers for disease progression and treatment efficacy.Circulating tumor cells (CTCs) and cancer exosomes are gaining influence as promising biomarkers in liquid biopsy, however, technologies that offer the dual- isolation of CTCs and exosomes have not been developed. Here, a microfluidic device is devised conjugated with melanoma cell adhesion molecule (MCAM) and melanoma- associated chondroitin sulfate proteoglycan (MCSP) for isolation and molecular profiling of both melanoma CTCs and exosomes. | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.publisher | American Cancer Society | |
dc.subject.other | circulating tumor cells | |
dc.subject.other | dual isolation and profiling | |
dc.subject.other | melanoma | |
dc.subject.other | microfluidics | |
dc.subject.other | tumor exosomes | |
dc.title | Dual- Isolation and Profiling of Circulating Tumor Cells and Cancer Exosomes from Blood Samples with Melanoma Using Immunoaffinity- Based Microfluidic Interfaces | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Materials Science and Engineering | |
dc.subject.hlbtoplevel | Engineering | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/163448/3/advs1971.pdf | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/163448/2/advs1971_am.pdf | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/163448/1/advs1971-sup-0001-SuppMat.pdf | en_US |
dc.identifier.doi | 10.1002/advs.202001581 | |
dc.identifier.source | Advanced Science | |
dc.identifier.citedreference | Y.- T. Kang, Y. J. Kim, J. Bu, S. Chen, Y.- H. Cho, H. M. Lee, C. J. Ryu, Y. Lim, S.- W. Han, Sens. Actuators, B 2018, 260, 320. | |
dc.identifier.citedreference | A. S. Azmi, B. Bao, F. H. Sarkar, Cancer Metastasis Rev. 2013, 32, 623. | |
dc.identifier.citedreference | D. K. Jeppesen, M. L. Hvam, B. Primdahl- Bengtson, A. T. Boysen, B. Whitehead, L. Dyrskjot, T. F. Orntoft, K. A. Howard, M. S. Ostenfeld, J. Extracell. Vesicles 2014, 3, 25011. | |
dc.identifier.citedreference | A. Cvjetkovic, J. Lotvall, C. Lasser, J Extracell. Vesicles 2014, 3, 23111. | |
dc.identifier.citedreference | I. Helwa, J. Cai, M. D. Drewry, A. Zimmerman, M. B. Dinkins, M. L. Khaled, M. Seremwe, W. M. Dismuke, E. Bieberich, W. D. Stamer, M. W. Hamrick, Y. Liu, PLoS One 2017, 12, e0170628. | |
dc.identifier.citedreference | S. Gholizadeh, M. Shehata- Draz, M. Zarghooni, A. Sanati- Nezhad, S. Ghavami, H. Shafiee, M. Akbari, Biosens. Bioelectron. 2017, 91, 588. | |
dc.identifier.citedreference | S. Jeong, J. Park, D. Pathania, C. M. Castro, R. Weissleder, H. Lee, ACS Nano 2016, 10, 1802. | |
dc.identifier.citedreference | J. Lotvall, A. F. Hill, F. Hochberg, E. Buzas, D. Di Vizio, C. Gardiner, Y. S. Gho, I. V. Kurochkin, S. Mathivanan, P. Quesenberry, S. Sahoo, H. Tahara, M. H. Wauben, K. W. Witwer, C. Thery, J Extracell. Vesicles 2014, 3, 26913. | |
dc.identifier.citedreference | R. Szatanek, J. Baran, M. Siedlar, M. Baj- Krzyworzeka, Int. J. Mol. Med. 2015, 36, 11. | |
dc.identifier.citedreference | G. Marsavela, C. A. Aya- Bonilla, M. E. Warkiani, E. S. Gray, M. Ziman, Cancer Lett. 2018, 424, 1. | |
dc.identifier.citedreference | P. Sharma, S. Ludwig, L. Muller, C. S. Hong, J. M. Kirkwood, S. Ferrone, T. L. Whiteside, J. Extracell. Vesicles 2018, 7, 1435138. | |
dc.identifier.citedreference | J. B. Freeman, E. S. Gray, M. Millward, R. Pearce, M. Ziman, J. Transl. Med. 2012, 10, 192. | |
dc.identifier.citedreference | X. Luo, D. Mitra, R. J. Sullivan, B. S. Wittner, A. M. Kimura, S. W. Pan, M. P. Hoang, B. W. Brannigan, D. P. Lawrence, K. T. Flaherty, L. V. Sequist, M. McMahon, M. W. Bosenberg, S. L. Stott, D. T. Ting, S. Ramaswamy, M. Toner, D. E. Fisher, S. Maheswaran, D. A. Haber, Cell Rep. 2014, 7, 645. | |
dc.identifier.citedreference | L. R. Volpatti, A. K. Yetisen, Trends Biotechnol. 2014, 32, 347. | |
dc.identifier.citedreference | J. Zhang, S. Yan, D. Yuan, G. Alici, N. T. Nguyen, M. E. Warkiani, W. Li, Lab Chip 2016, 16, 10. | |
dc.identifier.citedreference | J. Lim, M. Choi, H. Lee, J. Y. Han, Y. Cho, Front. Chem. 2019, 6, 664. | |
dc.identifier.citedreference | Y. - T. Kang, Y. J. Kim, T. H. Lee, J. - E. Shim, Y.- H. Cho, in Proc. of the American Association for Cancer Research Annual Meeting 2017, AACR, Philadelphia, PA 2017, 77, 1719. https://doi.org/10.1158/1538-7445.AM2017-1719 | |
dc.identifier.citedreference | V. Murlidhar, M. Zeinali, S. Grabauskiene, M. Ghannad- Rezaie, M. S. Wicha, D. M. Simeone, N. Ramnath, R. M. Reddy, S. Nagrath, Small 2014, 10, 4895. | |
dc.identifier.citedreference | V. Murlidhar, R. M. Reddy, S. Fouladdel, L. Zhao, M. K. Ishikawa, S. Grabauskiene, Z. Zhang, J. Lin, A. C. Chang, P. Carrott, W. R. Lynch, M. B. Orringer, C. Kumar- Sinha, N. Palanisamy, D. G. Beer, M. S. Wicha, N. Ramnath, E. Azizi, S. Nagrath, Cancer Res 2017, 77, 5194. | |
dc.identifier.citedreference | E. Lin, L. Rivera- Báez, S. Fouladdel, H. J. Yoon, S. Guthrie, J. Wieger, Y. Deol, E. Keller, V. Sahai, D. M. Simeone, M. L. Burness, E. Azizi, M. S. Wicha, S. Nagrath, Cell Syst. 2017, 5, 295. | |
dc.identifier.citedreference | J. Yang, M. A. Price, C. L. Neudauer, C. Wilson, S. Ferrone, H. Xia, J. Iida, M. A. Simpson, J. B. McCarthy, J. Cell Biol. 2004, 165, 881. | |
dc.identifier.citedreference | C. A. Aya- Bonilla, G. Marsavela, J. B. Freeman, C. Lomma, M. H. Frank, M. A. Khattak, T. M. Meniawy, M. Millward, M. E. Warkiani, E. S. Gray, M. Ziman, Oncotarget 2017, 8, 67355. | |
dc.identifier.citedreference | T. Nomura, W. C. Huang, H. E. Zhau, S. Josson, H. Mimata, M. Kaur, Anticancer Agents Med. Chem. 2014, 14, 343. | |
dc.identifier.citedreference | K. Yoshimura, K. Takeuchi, K. Nagasaki, S. Ogishima, H. Tanaka, T. Iwase, F. Akiyama, Y. Kuroda, Y. Miki, Mol. Med. Rep. 2009, 2, 549. | |
dc.identifier.citedreference | H. Tomita, K. Tanaka, T. Tanaka, A. Hara, Oncotarget 2016, 7, 11018. | |
dc.identifier.citedreference | A. Satelli, S. Li, Cell. Mol. Life Sci. 2011, 68, 3033. | |
dc.identifier.citedreference | Y. Cheli, V. F. Bonnazi, A. Jacquel, M. Allegra, G. M. De Donatis, P. Bahadoran, C. Bertolotto, R. Ballotti, Oncotarget 2014, 5, 5272. | |
dc.identifier.citedreference | A. D. Boiko, O. V. Razorenova, M. van de Rijn, S. M. Swetter, D. L. Johnson, D. P. Ly, P. D. Butler, G. P. Yang, B. Joshua, M. J. Kaplan, M. T. Longaker, I. L. Weissman, Nature 2010, 466, 133. | |
dc.identifier.citedreference | R. Barnawi, S. Al- Khaldi, D. Colak, A. Tulbah, T. Al- Tweigeri, M. Fallatah, D. Monies, H. Ghebeh, M. Al- Alwan, Int. J. Cancer 2019, 145, 830. | |
dc.identifier.citedreference | Y.- T. Kang, E. Purcell, C. Palacios- Rolston, T.- W. Lo, N. Ramnath, S. Jolly, S. Nagrath, Small 2019, 15, 1903600. | |
dc.identifier.citedreference | T. D. Schmittgen, K. J. Livak, Nat. Protoc. 2008, 3, 1101. | |
dc.identifier.citedreference | K. J. Livak, T. D. Schmittgen, Methods 2001, 25, 402. | |
dc.identifier.citedreference | F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre, A. Jemal, Ca- Cancer J. Clin. 2018, 68, 394. | |
dc.identifier.citedreference | R. L. Siegel, K. D. Miller, A. Jemal, Ca- Cancer J. Clin. 2020, 70, 7. | |
dc.identifier.citedreference | American Cancer Society, Cancer Facts & Figures 2020, American Cancer Society, Atlanta, GA 2020. | |
dc.identifier.citedreference | A. Sandru, S. Voinea, E. Panaitescu, A. Blidaru, J. Med. Life 2014, 7, 572. | |
dc.identifier.citedreference | M. B. G. Cristofanilli, M. J. Ellis, A. Stopeck, J. Matera, M. C. Miller, J. M. Reuben, G. V. Doyle, W. J. Allard, L. W. Terstappen, D. F. Hayes, N. Engl. J. Med. 2004, 351, 781. | |
dc.identifier.citedreference | K. Bluemke, U. Bilkenroth, A. Meye, S. Fuessel, C. Lautenschlaeger, S. Goebel, A. Melchior, H. Heynemann, P. Fornara, H. Taubert, Cancer Epidemiol., Biomarkers Prev. 2009, 18, 2190. | |
dc.identifier.citedreference | S. J. Cohen, C. J. Punt, N. Iannotti, B. H. Saidman, K. D. Sabbath, N. Y. Gabrail, J. Picus, M. Morse, E. Mitchell, M. C. Miller, G. V. Doyle, H. Tissing, L. W. Terstappen, N. J. Meropol, J. Clin. Oncol. 2008, 26, 3213. | |
dc.identifier.citedreference | S. Nagrath, L. V. Sequist, S. Maheswaran, D. W. Bell, D. Irimia, L. Ulkus, M. R. Smith, E. L. Kwak, S. Digumarthy, A. Muzikansky, P. Ryan, U. J. Balis, R. G. Tompkins, D. A. Haber, M. Toner, Nature 2007, 450, 1235. | |
dc.identifier.citedreference | J. W. Po, Y. Ma, B. Balakrishna, D. Brungs, F. Azimi, P. de Souza, T. M. Becker, PLoS One 2019, 14, e0211866. | |
dc.identifier.citedreference | S. D. Wit, G. V. Dalum, A. T. M. Lenferink, A. G. J. Tibbe, T. J. N. Hiltermann, H. J. M. Groen, C. J. M. V. Rijn, L. W. M. M. Terstappen, Sci. Rep. 2015, 5, 12270. | |
dc.identifier.citedreference | Johnson & Johnson. Veridex Launches CELLTRACKS® Circulating Melanoma Cell Kit For Research Use. Raritan, NJ, https://www.jnj.com/media-center/press-releases/veridex-launches-celltracks-circulating-melanoma-cell-kit-for-research-use (accessed: 24 July 2020). | |
dc.identifier.citedreference | Veridex LLC, CELLTRACK® Circulating Melanoma Cell Kit INSTRAUCTIONS FOR USE, https://www.cellsearchruo.com/sites/default/files/docs/products/MSB03103.pdf (accessed: 24 July 2020). | |
dc.identifier.citedreference | L. Khoja, P. Lorigan, C. Zhou, M. Lancashire, J. Booth, J. Cummings, R. Califano, G. Clack, A. Hughes, C. Dive, J. Invest. Dermatol. 2013, 133, 1582. | |
dc.identifier.citedreference | C. Rao, T. Bui, M. Connelly, G. Doyle, I. Karydis, M. R. Middleton, G. Clack, M. Malone, F. A. Coumans, L. W. Terstappen, Int. J. Oncol. 2011, 38, 755. | |
dc.identifier.citedreference | M. Ilie, V. Hofman, E. Long, O. Bordone, E. Selva, K. Washetine, C. H. Marquette, P. Hofman, Ann. Transl. Med. 2014, 2, 107. | |
dc.identifier.citedreference | B. N. Hannafon, W. Q. Ding, Int. J. Mol. Sci. 2013, 14, 14240. | |
dc.identifier.citedreference | C. Thery, L. Zitvogel, S. Amigorena, Nat. Rev. Immunol. 2002, 2, 569. | |
dc.identifier.citedreference | C. Thery, M. Ostrowski, E. Segura, Nat. Rev. Immunol. 2009, 9, 581. | |
dc.identifier.citedreference | D. D. Taylor, C. Gercel- Taylor, Semin. Immunopathol. 2011, 33, 441. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.